Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

Published:2017-01-23 Issue: Volume:4 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Lazzari Chiara,Bulotta Alessandra,Ducceschi Monika,Viganò Maria Grazia,Brioschi Elena,Corti Francesca,Gianni Luca,Gregorc Vanesa

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Frontiers Media SA

Subject

General Medicine

Reference79 articles.

1. Global cancer incidence and mortality rates and trends – an update;Torre;Cancer Epidemiol Biomarkers Prev,2016

2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

3. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group;Fossella;J Clin Oncol,2003

4. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

5. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil;Reck;J Clin Oncol,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods;Gene;2024-08

2. Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world study;Future Oncology;2024-04-22

3. Clinical outcomes and medical resource utilization of toripalimab combination therapy versus bevacizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer;Current Medical Research and Opinion;2024-01-22

4. hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox;Genetic Testing and Molecular Biomarkers;2023-12-01

5. Synergistic effect of docetaxel and gambogic acid on bone metastasis of lung cancer;Bulletin du Cancer;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3